Physician profile
David C Santamore
NPI 1750349536
$343.51
in general payments reported to CMS, 2019-2025
9 companies · $70.78 in 2025
The $70.78 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $33.63 · 2021: $41.69 · 2023: $38.18 · 2024: $19.24 · 2025: $70.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $128.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Comsort, INC | $100.00 | 2019 | |
| Glaukos Corporation | $76.24 | 2023-2025 | Idose, Istent Infinite Trabecular Micro-Bypass System Model Is3, Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3 |
| Johnson & Johnson Surgical Vision, INC. | $33.40 | 2025 | Tecnis Iol, Tecnis Iol |
| Ivantis, INC | $32.85 | 2020-2021 | |
| Rxsight INC | $23.14 | 2021 | |
| Carl Zeiss Meditec, INC. | $22.95 | 2019 | |
| Omeros Corporation | $19.33 | 2020 | |
| Harrow Eye, LLC | $18.56 | 2025 | Triesence |
| Eyepoint US, INC. | $17.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Santamore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.